Skip to main content
OpenTrials
Completed

NCT Number: NCT01988532

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult males able to provide consent and complete a survey in English
  • Congenital hemophilia A or B with or without inhibitors with any history of joint bleeding or joint pain
  • Presentation at the treatment center for a comprehensive annual visit where joint range of motion will be obtained
  • Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)

Exclusion criteria

  • Previous participation in this study

Treatment and study plan

No treatment given

Other

Subject will only fill out a questionnaire

Primary outcomes

  1. Prevalence of acute (bleed-related) pain (percentage)

    Time frame: At the first visit (only one study visit)

  2. Prevalence of chronic (arthritic) pain (percentage)

    Time frame: At the first visit (only one study visit)

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Nov 20, 2013
Registry last updated
Jan 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.